Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human

Autonomic Neuroscience: Basic and Clinical

Volumn 126-127, Issue , 2006, Pages 232-249

  Lecci, Alessandro ^a   Capriati, Angela ^a   Altamura, Maria ^a   Maggi, Carlo Alberto ^b  

^a Menarini Ricerche   (Italy)

^b Direction of Discovery and Development   (Italy)

Author keywords

Bowel habits; Clinical studies; Colon; Compliance; Intestine; Nepadutant; Neurokinin A; Neurokinin B; NK1 receptors; NK2 receptors; NK3 receptors; Tachykinins

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; ATROPINE; BENZOYLALANYLALANYL DEXTRO TRYPTOPHYLPHENYLALANYL DEXTRO PROLYLPROLYLNORLEUCINAMIDE; CYCLOPIAZONIC ACID; ENEMA; GLYCEROL; L 668169; MEN 10627; MUSCARINIC RECEPTOR BLOCKING AGENT; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; NEPADUTANT; NEUROKININ 1 RECEPTOR ANTAGONIST; NEUROKININ 2 RECEPTOR; NEUROKININ 2 RECEPTOR ANTAGONIST; NEUROKININ A; NEUROKININ A [4-10][5 TYROSINE 6,8,9 DEXTRO TRYPTOPHAN 10 LYSINE]; NEUROKININ B; NIFEDIPINE; NOLPITANTIUM; PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN]; REGULATOR PROTEIN; SAREDUTANT; SEROTONIN 3 ANTAGONIST; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR; THAPSIGARGIN; UNCLASSIFIED DRUG;

ACCURACY; ANATOMY; ANIMAL; BALLOON DILATATION; BINDING AFFINITY; CELL STIMULATION; CHOLINERGIC NERVE CELL; CLINICAL TRIAL; COLON; COLON MUCOSA; COLON SECRETION; COMPLIANCE (PHYSICAL); DEFECATION HABIT; DRUG EFFECT; DRUG RECEPTOR BINDING; ELECTRIC FIELD; ELECTRICITY; EVIDENCE BASED MEDICINE; EXPERIMENTATION; FECES; FUNCTIONAL ASSESSMENT; GASTROINTESTINAL TRACT; HUMAN; IN VITRO STUDY; INTERNEURON; INTESTINAL DYSMOTILITY; INTESTINE; INTESTINE CONTRACTION; INTESTINE INNERVATION; INTESTINE MOTILITY; MOLECULAR MODEL; MOTONEURON; MOTOR PERFORMANCE; MUSCLE; NERVE STIMULATION; NEUROMUSCULAR SYNAPSE; NONHUMAN; PERCEPTION; PHYSIOLOGY; PRIORITY JOURNAL; PROCTOCOLITIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RECTUM; REGULATORY MECHANISM; REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; SMALL INTESTINE ABSORPTION; SMOOTH MUSCLE; SMOOTH MUSCLE TONE; SPECIES;

ANIMALS; DIGESTIVE SYSTEM DISEASES; GASTROINTESTINAL TRACT; HUMANS; RECEPTORS, NEUROKININ-2; RECEPTORS, TACHYKININ; TACHYKININS;

EID: 33744832395     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2006.02.014     Document Type: Review

References (143)

1. Accili E.A., Dhatt N., and Buchan A.M. Neural somatostatin, vasoactive intestinal peptide and substance P in canine and human jejunum. Neurosci. Lett. 185 (1995) 37-40
2. Al-Saffar A., and Hellstrom P.M. Contractile responses to natural tachykinins and selective tachykinin analogs in normal and inflamed ileal and colonic muscle. Scand. J. Gastroenterol. 36 (2001) 485-493
3. Bandari P.S., Qian J., Oh H.S., Potian J.A., Yehia G., Harrison J.S., and Rameshwar P. Crosstalk between neurokinin receptor is relevant to hematopoietic regulation: cloning and characterisation of neurokinin-2 promoter. J. Neuroimmunol. 138 (2003) 65-75
4. Bartho L., Lenard Jr. L., Patacchini R., Halmai V., Holzer P., and Maggi C.A. Tachykinin receptors are involved in the "local efferent" motor response to capsaicin in the guinea-pig small intestine. Neuroscience 90 (1999) 221-228
5. Bayguinov O., Hagen B., and Sanders K. Substance P modulates localized calcium transients and membrane current responses in murine colonic myocytes. Br. J. Pharmacol. 138 (2003) 1233-1243
6. Bellucci F., Meini S., Catalioto R.-M., Catalani C., Giuliani S., Quartara L., Giolitti S., Faiella A., Rotondaro L., Luz Candenas M., Pinto F., and Maggi C.A. Pharmacological evaluation of alpha and beta human tachykinin NK2 receptor splice variants expressed in CHO cells. Eur. J. Pharmacol. 499 (2004) 229-238
7. Benko R., Lazar Z., Undi S., Antal A., Horvath O.P., Rumbus Z., Wolf M., Maggi C.A., and Bartho L. Inhibition of nitric oxide synthesis blocks the inhibitory response to capsaicin in intestinal circular muscle preparations from different species. Life Sci. 76 (2005) 2773-2782
8. Bernstein C.N., Robert M.E., and Eysselein V.E. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease. Am. J. Gastroenterol. 88 (1993) 908-913
9. Bian X.C., Bertrand P.P., Furness J.B., and Bornstein J.C. Evidence for functional NK1-tachykinin receptors on motor neurons supplying the circular muscle of guinea-pig small and large intestine. Neurogastroenterol. Motil. 12 (2000) 307-315
10. Bischoff S.C., Schwengberg S., Lorentz A., Manns M.P., Bektas H., Sann H., Levi-Schaffer L., Shanahan F., and Schemann M. Substance P and other neuropeptides do not induce mediator release in isolated human intestinal mast cells. Neurogastroenterol. Motil. 16 (2004) 185-193
11. Bosshard A., Chery-Croze S., Cuber J.C., Dechelette M.A., Berger F., and Chayvialle J.A. Immunocytochemical study of peptidergic structures in Brunner's glands. Gastroenterology 97 (1989) 1382-1388
12. Bouin M., Delvaux M., Blanc C., Lagier E., Delisle M.-B., Fioramonti J., Bueno L., and Frexinos J. Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance. Eur. J. Gastroenterol. Hepatol. 13 (2001) 573-580
13. Boutaghou-Cherid H., Porcher C., Liberge M., Jule Y., Bunnett N.W., and Christen M.O. Expression of the neurokinin type 1 receptor in the human colon. Auton. Neurosci.: Basic Clin. 124 (2005) 9-17
14. Brehmer A., Croner R., Dimmler A., Papadopulos T., Schrodl F., and Neuhuber W. Immunohistochemical characterisation of putative primary afferent (sensory) myenteric neurons in human small intestine. Auton. Neurosci.: Basic Clin. 112 (2004) 49-59
15. Brehmer A., Lindig T.M., Schrodl F., Neuhuber W., Ditterich D., Rexer M., and Rupprecht H. Morphology of enkephalin-immunoreactive myenteric neurons in the human gut. Histochem. Cell Biol. 123 (2005) 131-138
16. Brodin E., Sjolund K., Hakanson R., and Sundler F. Substance P-containing nerve fibres are numerous in human but not in feline intestinal mucosa. Gastroenterology 85 (1983) 557-564
17. Cao W., Pricolo V.E., Zhang L., Behar J., Biancani P., and Kirber M.T. Gq-linked NK2 receptors mediate neurally induced contraction of human sigmoid circular smooth muscle. Gastroenterology 119 (2000) 51-61
18. Cao W., Potenti F.M., and Pricolo V.E. NK2 receptors mediate spontaneous contractions of human sigmoid circular muscle. Gastroenterology 126 (2004) A-222-A-223
19. Cao W., Vrees M.D., Kirber M.T., Fiocchi C., and Pricolo V.E. Hydrogen peroxide contributes to motor dysfunction in ulcerative colitis. Am. J. Physiol.: Gastrointest. Liver Physiol. 286 (2004) G833-G843
20. Cao W., Vrees M.D., Potenti F.M., Harnett K.M., Fiocchi C., and Pricolo V.E. Interleukin 1beta-induced production of H2O2 contributes to reduced sigmoid colonic circular smooth muscle contractility in ulcerative colitis. J. Pharmacol. Exp. Ther. 311 (2005) 60-70
21. Carini F., Lecci A., Tramontana M., Giuliani S., and Maggi C.A. Tachykinin NK2 receptors and enhancement of cholinergic transmission in the inflamed rat colon: an in vivo motility study. Br. J. Pharmacol. 133 (2001) 1107-1113
22. 2 receptor antagonist. Br. J. Pharmacol. 123 (1998) 81-91
23. Corboz M.R., Fernandez X., Rizzo C.A., Tozzi S., Monahan M.E., and Hey J.A. Increasing blocking activity of combined tachykinin NK1 and NK2 receptor antagonists on tachykinergic bronchomotor responses in the guinea-pig. Auton. Autacoid Pharmacol. 23 (2003) 79-93
24. Croci T., Aureggi G., Manara L., Emonds-Alt X., Le Fur G., Maffrand J.-P., Mukenge S., and Ferla G. In vitro characterisation of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips. Br. J. Pharmacol. 124 (1998) 1321-1327
25. Crowe R., and Burnstock G. The subserosal ganglia of the human taenia. Neurosci. Lett. 119 (1990) 203-2056
26. Crowe R., Kamm M.A., Burnstock G., and Lennard-Jones J.E. Peptide-containing neurons in different regions of the submucous plexus of human sigmoid colon. Gastroenterology 102 (1992) 461-467
27. Delvaux M. Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome. Gut 51 suppl. 1 (2002) 57-61
28. Dery O., Defea K.A., and Bunnett N.W. Protein kinase C-mediated desensitisation of the neurokinin-1 receptor. Am. J. Physiol., Cell Physiol. 280 (2001) C1097-C1106
29. Di Sebastiano P., Fink T., Di Mola F.F., Weihe E., Innocenti P., Friess H., and Buchler M.W. Neuroimmune appendicitis. Lancet 354 (1999) 461-466
30. Domoto T., Oki M., Kotoh T., and Nakamura T. Heterogenous distribution of peptide-containing nerve fibres within the circular muscle layer of the human pylorus. Clinic. Auton. Res. 2 (1992) 403-407
31. Dong W.Z., Zou D.W., Li Z.S., Zou X.P., Zhu A.Y., Xu G.M., Yin N., Gong Y.F., Sun Z.X., and Man X.H. Study of visceral hypersensitivity in irritable bowel syndrome. Chin. J. Dig. Dis. 5 (2004) 103-109
32. Drewes A.M., Schipper K.-P., Dimcevski G., Petersen P., Gregersen H., Funch-Jansen P., and Arendt-Nielsen L. Gut pain and hyperalgesia induced by capsaicin: a human experimental model. Pain 104 (2003) 333-341
33. Ekblad E., Arnbjornsson E., Ekmann R., Hakanson R., and Sundler F. Neuropeptides in the human appendix. Distribution and motor effects. Dig. Dis. Sci. 34 (1989) 1217-1230
34. Ferri G.L., Botti P.L., Vezzadini P., Biliotti G., Bloom S.R., and Polak J.M. Peptide-containing innervation of the human intestinal mucosa. An immunocytochemical study on whole-mount preparations. Histochemistry 76 (1982) 413-420
35. Ferri G.L., Adrian T.E., Ghatei M.A., O'Shaughnessy D.J., Probert L., Lee Y.C., Buchan A.M., Polak J.M., and Bloom S.R. Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology 84 (1983) 777-786
36. Ferri G.L., Botti P., Biliotti G., Ribecchi L., Bloom S.R., Tonelli L., Labo G., and Polak J.M. VIP-, substance P- and met-enkephalin-immunoreactive innervation of the human gastroduodenal mucosa and Brunner's glands. Gut 25 (1984) 948-952
37. Ferri G.L., Adrian T.E., Allen J.M., Soimero L., Cancellieri A., Yeast J.C., Blank M., Polak J.M., and Bloom S.K. Intramural distribution of regulatory peptides in the sigmoid-recto-anal region of the human gut. Gut 29 (1988) 762-768
38. Ferri G.L., Adrian T.E., Soimero L., Blank M., Cavalli D., Biliotti G., Polak J.M., and Bloom S.R. Intramural distribution of immunoreactive vasoactive intestinal polypeptide (VIP), substance P, somatostatin and mammalian bombesin in the oesophago-gastro-pyloric region of the human gut. Cell Tissue Res. 256 (1989) 191-197
39. Furness J.B. Types of neurons in the enteric nervous system. J. Auton. Nerv. Syst. 81 (2000) 87-96
40. Furness J.B., Kumano K., Larsson H., Kunze W.A., and Vogalis F. Sensitisation of enteric reflexes in the rat colon in vitro. Auton. Neurosci. 97 (2002) 19-25
41. Giuliani S., Barbanti G., Turini D., Quartara L., Rovero P., Giachetti A., and Maggi C.A. NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterisation of the NK2 receptor subtype. Eur. J. Pharmacol. 203 (1991) 365-370
42. Giuliani S., Tramontana M., Lecci A., and Maggi C.A. Tachykinin receptors mediate atropine-resistant rat duodenal contractions in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 327-335
43. Giuliani S., Guelfi M., Toulouse M., Bueno L., Lecci A., Tramontana M., Criscuoli M., and Maggi C.A. Effect of a tachykinin NK2 receptor antagonist, nepadutant, on cardiovascular and gastrointestinal function in rats and dogs. Eur. J. Pharmacol. 415 (2001) 61-71
44. Goldin E., Karmeli F., Selinger Z., and Rachmilewitz D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig. Dis. Sci. 34 (1989) 754-757
45. Goode T., O'Connell J., Sternini C., Anton P., Wong H., O'Sullivan G.C., Collins J.K., and Shanahan F. Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization. J. Immunol. 161 (1998) 2232-2240
46. Goode T., O'Connell J., Anton P., Wong H., Reeve J., O'Sullivan G.C., Collins J.K., and Shanahan F. Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation. Gut 47 (2000) 387-396
47. Goode T., O'Connor T., Hopkins A., Moriatry D., O'Sullivan G.C., Collins J.K., O'Donoghue D., Baird A.W., O'Connell J., and Shanahan F. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P. J. Cell. Physiol. 197 (2003) 30-41
48. Grider J.R. Identification of neurotransmitters regulating intestinal peristaltic reflex in humans. Gastroenterology 97 (1989) 1414-1419
49. Guagnini F., Valenti M., Mukenge S., Matias I., Bianchetti A., Di Palo S., Ferla G.F., Di Marzo V., and Croci T. Neural Contractions in Colonic Strips from Patients with Diverticulosis: Role of Endocannabinoids and Substance P. Gut Published Online 19 Jan 2006 (2006) 10.1136/gut.2005.076372
50. Heitz P., Polak J.M., Timson D.M., and Pearse A.G. Enterochromaffin cells as the endocrine source of gastrointestinal substance P. Histochemistry 49 (1976) 343-347
51. Hens J., Vanderwinden J.M., De Laet M.H., Scheuermann D.W., and Timmermans J.P. Morphological and neurochemical identifications of enteric neurones with mucosal projections in the human small intestine. J. Neurochem. 76 (2001) 464-471
52. Hillingso J.G., Kjeldsen J., Schmidt P.T., Rasmussen T.N., Fisher-Hansen B., Holst J.J., Lauristen K., Bukhave K., and Rask-Madsen J. Effects of topical ropivacaine on eicosanoids and neurotransmitters in the rectum of patients with distal ulcerative colitis. Scand. J. Gastroenterol. 37 (2002) 325-329
53. Hockerfelt U., Franzen L., Norrgard O., and Forsgren S. Early increase and later decrease in VIP and substance P nerve fiber densities following abdominal radiotherapy: a study in human colon. Int. J. Radiat. Biol. 78 (2002) 1045-1053
54. Holzer P. Involvement of nitric oxide in the substance P-induced inhibition of intestinal peristalsis. NeuroReport 8 (1997) 2857-2860
55. Holzer P., and Holzer-Petsche U. Tachykinin receptors in the gut: physiological and pathological implications. Curr. Opin. Pharmacol. 1 (2001) 583-590
56. Huber O., Bertrand C., Bunnett N.W., Pellegrini C.A., Nadel J.A., Nakazato P., Debas H.T., and Geppetti P. Tachykinins contract the circular muscle of the human esophageal body in vitro via NK2 receptors. Gastroenterology 105 (1993) 981-987
57. Hutson J.M., McNamara J., Gibb S., and Shin Y.M. Slow transit constipation in children. J. Paediatr. Child Health 37 (2001) 426-430
58. Jaafari N., Liberge M., Christen M.-O., and Jule Y. Comparative distribution of NK1, NK2 and NK3 receptors in the ganglionated plexus and external muscle layers of the human colon. Gastroenterology 126 Suppl. 2 (2004) A-217
59. Johansson J.F., Carney J.A., Go V.L., and Koch T.R. Segmental distribution of colonic neuropeptides in Hirschsprung's disease. Regul. Pept. 36 (1991) 56-69
60. Jonsson M., Norrgard O., and Forsgren S. Substance P and neurokinin-1 receptor in relation to eosinophilia in ulcerative colitis. Peptides 26 (2005) 799-814
61. Joos G.F., Vincken W., Louis R., Schelfhout V.J., Wang J.H., Shaw M.J., Cioppa G.D., and Pauwels R.A. Dual tachykinin NK1/NK2 antagonist DNK333 inhibits neurokinin A-induced bronchoconstriction in asthma patients. Eur. Respir. J. 23 (2004) 76-81
62. Keast J.R., Furness J.B., and Costa M. Distribution of certain peptide-containing nerve fibres and endocrine cells in the gastrointestinal mucosa in five mammalian species. J. Comp. Neurol. 236 (1985) 403-422
63. Khan I., and Collins S.M. Fourth isoform of preprotachykinin messenger RNA encoding for substance P in the rat intestine. Biochem. Biophys. Res. Commun. 114 (1994) 533-540
64. Koch T.R., Carney J.A., and Go V.L. Distribution and quantification of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig. Dis. Sci. 32 (1987) 369-376
65. Krysiak P.S., and Preiksaitis H.G. Tachykinins contribute to nerve-mediated contractions in the human esophagus. Gastroenterology 120 (2001) 39-48
66. Kimura M., Masuda T., Hiwatashi N., Toyota T., and Natura H. Changes in neuropeptide-containing nerves in human colonic mucosa with inflammatory bowel disease. Pathol. Int. 44 (1994) 624-634
67. Kishimoto S., Tateishi K., Kobayashi H., Kobuke K., Hagio T., Matsuoka Y., Kajiyama G., and Miyoshi A. Distribution of neurokinin A-like and neurokinin B-like immunoreactivity in human peripheral tissues. Regul. Pept. 36 (1991) 165-171
68. Kojima S., Ueda S., Ikeda M., and Kamikawa Y. Calcitonin gene-related peptide facilitates serotonin release from guinea-pig colonic mucosa via myenteric neurons and tachykinin NK2/NK3 receptors. Br. J. Pharmacol. 141 (2004) 385-390
69. Kolbel C.B., Mayer E.A., Holtmann G., Layer P., Petschulat W., and Erhard J. Effects of neurokinins on human colonic motility. Neurogastroenterol. Motil. 6 (1994) 119-127
70. Kurtz M.M., Wang R., Clements M.K., Cascieri M.A., Austin C.P., Cunningham B.R., Chicchi G.G., and Liu Q. Identification, localisation, and receptor characterisation of novel mammalian substance P-like peptides. Gene 296 (2002) 205-212
71. Lecci A., and Maggi C.A. Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases. Expert Opin. Ther. Targets 7 (2003) 343-362
72. Lecci A., Giuliani S., Tramontana M., Santicioli P., Criscuoli M., Dion S., and Maggi C.A. Bladder distension and activation of the efferent function of sensory fibres: similarities with the effect of capsaicin. Br. J. Pharmacol. 124 (1998) 259-266
73. Lecci A., Santicioli P., and Maggi C.A. Pharmacology of transmission to gastrointestinal muscle. Curr. Opin. Pharmacol. 2 (2002) 630-641
74. Lecci A., Capriati A., and Maggi C.A. Tachykinin NK2 receptor antagonists for the treatment of irritable bowel syndrome. Br. J. Pharmacol. 141 (2004) 1249-1263
75. Lee C.M., Kumar R.K., Lubowski D.Z., and Burcher E. Neuropeptides and nerve growth in inflammatory bowel diseases: a quantitative immunohistochemical study. Dig. Dis. Sci. 47 (2002) 495-502
76. Li H., Leeman S.E., Slack B.E., Hauser G., Saltman W.S., Krause J.E., Blusztajn J.K., and Boyd N.D. A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 9475-9480
77. Lippi A., Santicioli P., Criscuoli M., and Maggi C.A. Depolarisation evoked co-release of tachykinins from enteric nerves in the guinea-pig proximal colon. Naunyn-Schmiedeberg's Arch. Pharmacol. 357 (1998) 245-251
78. Liu L., Shang F., Markus I., and Burcher E. Roles of substance P receptors in human colon circular muscle: alterations in diverticular disease. J. Pharmacol. Exp. Ther. 302 (2002) 627-635
79. Llewellyn-Smith I.J., Furness J.B., Murphy R., O'Brien P., and Costa E. Substance P-containing nerves in the human small intestine. Gastroenterology 86 (1984) 421-435
80. Lordal M., Theodorsson E., and Hellstrom P.M. Tachykinins influence interdigestive rhythm and contractile strength of human small intestine. Dig. Dis. Sci. 42 (1997) 1940-1949
81. Lordal M., Navalesi G., Theodorsson E., Maggi C.A., and Hellstrom P.M. A novel tachykinin NK2 receptor antagonist prevents motility-stimulating effects of neurokinin A in small intestine. Br. J. Pharmacol. 134 (2001) 215-223
82. Maggi C.A. Principles of tachykininergic co-transmission in the peripheral and enteric nervous system. Regul. Pept. 93 (2000) 53-64
83. Maggi C.A., and Schwartz T.W. The dual nature of the tachykinin NK1 receptor. Trends Pharmacol. Sci. 18 (1997) 351-355
84. Maggi C.A., Patacchini R., Santicioli P., Giuliani S., Turini D., Barbanti G., Misuri D., and Meli A. Specific motor effects of capsaicin on human jejunum. Eur. J. Pharmacol. 149 (1988) 393-395
85. Maggi C.A., Patacchini R., Santicioli P., Giuliani S., Turini D., Barbanti G., Beneforti P., Misuri D., and Meli A. Human isolated small intestine: motor responses of the longitudinal muscle to fields stimulation and exogenous neuropeptides. Naunyn Schmiedeberg's Arch. Pharmacol. 339 (1989) 415-423
86. Maggi C.A., Theodorsson E., Santicioli P., Patacchini R., Barbanti G., Turini D., Renzi D., and Giachetti A. Motor response of the human isolated colon to capsaicin and its relationship to release of vasoactive intestinal peptide. Neuroscience 39 (1990) 833-841
87. Maggi C.A., Patacchini R., Santicioli P., Giuliani S., Turini D., Barbanti G., Giachetti A., and Meli A. Human isolated ileum: motor responses of the circular muscle to electrical field stimulation and exogenous neuropeptides. Naunyn Schmiedeberg's Arch. Pharmacol. 341 (1990) 256-261
88. Maggi C.A., Giuliani S., Patacchini R., Santicioli P., Theodorsson E., Barbanti G., Turini D., and Giachetti A. Tachykinin antagonists inhibit nerve-mediated contractions in the circular muscle of the human ileum. Gastroenterology 102 (1992) 88-96
89. Makridis C., Theodorsson E., Akerstrom G., Oberg K., and Knutson L. Increased intestinal non-substance P tachykinin concentrations in malignant midgut carcinoid disease. J. Gastroenterol. Hepatol. 14 (1999) 500-507
90. Maselli M.A., Piepoli A.L., Guerra V., Caruso M.L., Pezzolla F., Lorusso D., Demma I., and De Ponti F. Colonic smooth muscle responses in patients with diverticular disease of the colon: effect of the NK2 receptor antagonist SR48968. Dig. Liver Dis. 36 (2004) 348-354
91. Mazumdar S., and Das K.M. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Am. J. Gastroenterol. 87 (1992) 176-181
92. Mearin F., Zarate N., Sardi J.A., Moreno-Osset E., and Salis G. Traveler's constipation. Am. J. Gastroenterol. 98 (2003) 507-509
93. Menzies J.R.W., McKee R., and Corbett A.D. Differential alterations in tachykinin NK2 receptors in isolated colonic circular smooth muscle in inflammatory bowel disease and idiopathic chronic constipation. Regul. Pept. 99 (2001) 151-156
94. Metwali A., Blum A.M., Ferraris L., Klein J.S., Fiocchi C., and Weinstock J.V. Eosinophils within the healthy or inflamed human intestine produce substance P and vasoactive intestinal peptide. J. Neuroimmunol. 52 (1994) 69-78
95. Milner P., Crowe R., Kamm M.A., Lennard-Jones J.E., and Burnstock G. Vasoactive intestinal polypeptide levels in sigmoid colon in idiopathic constipation and diverticular disease. Gastroenterology 99 (1990) 666-675
96. Mitolo-Chieppa D., Mansi G., Nacci C., De Salvia M.A., Montagnani M., Potenza M.A., Rinaldi R., Lerro G., Siro-Brigiani G., Mitolo C.I., Rinaldi M., Altomare D.F., and Memeo V. Idiopathic chronic constipation: tachykinins as cotransmitters in colonic contraction. Eur. J. Clin. Investig. 31 (2001) 349-355
97. Mulè F., D'Angelo S., Tabacchi G., and Serio R. Involvement of tachykinin NK2 receptors in the modulation of spontaneous motility in rat proximal colon. Neurogastroenterol. Motil. 12 (2000) 459-466
98. Neunlist M., Aubert P., Toquet C., Oreshkova T., Barouk J., Lehur P.A., Schemann M., and Galmiche J.P. Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut 52 (2003) 84-90
99. Niess J.H., Monnikes H., Dignass A.U., Klapp B.F., and Arck P.C. Review on the influence of stress on immune mediators, neuropeptides and hormones with relevance for inflammatory bowel disease. Digestion 65 (2002) 131-140
100. Oh E.J., Gover T.D., Cordoba-Rodriguez R., and Weinreich D. Substance P evokes cation currents through TRP channels in HEK293 cells. J. Neurophysiol. 90 (2003) 2069-2073
101. Onori L., Aggio A., Taddei G., and Tonini M. Contribution of NK2 tachykinin receptors to propulsion in the rabbit distal colon. Am. J. Physiol. 278 (2000) G137-G147
102. O'Riordan A.M., Quinn T., Hyland J.M., O'Donoghue D.P., and Baird A.W. Sources of calcium in neurokinin A-induced contractions of human colonic smooth muscle in vitro. Am. J. Gastroenterol. 96 (2001) 3117-3121
103. Page N.M. Hemokinins and endokinins. Cell. Mol. Life Sci. 61 (2004) 1652-1663
104. Page N.M., and Bell N.J. The human tachykinin NK1 (short form) and tachykinin NK4 receptor: a reappraisal. Eur. J. Pharmacol. 437 (2002) 27-30
105. Palsson O.S., Morteau O., Bozymski E.M., Woosley J.T., Sartor R.B., Davies M.J., Johnson D.A., Turner M.J., and Whitehead W.E. Elevated vasoactive intestinal peptide concentrations in patients with irritable bowel syndrome. Dig. Dis. Sci. 49 (2004) 1236-1243
106. Patacchini R., Bartho L., De Giorgio R., Lenard Jr. L., Stanghellini V., Barbara G., Lecci A., and Maggi C.A. Involvement of endogenous tachykinins and CGRP in the motor responses produced by capsaicin in the guinea-pig common bile duct. Naunyn-Schmiedeberg's Arch. Pharmacol. 360 (1999) 344-353
107. Patacchini R., Giuliani S., Turini A., Navarra G., and Maggi C.A. Effect of nepadutant at tachykinin NK2 receptors in human intestine and urinary bladder. Eur. J. Pharmacol. 398 (2000) 389-397
108. Patel H.J., Ramikissoon S.H., Patel P.S., and Rameshwar P. Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 17436-17441
109. Pennefather J.N., Lecci A., Luz Candenas M., Patak E., Pinto F.M., and Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci. 74 (2004) 1445-1463
110. Porter A.J., Wattchow D.A., Hunter A., and Costa M. Abnormalities of nerve fibers in the circular muscle of patients with slow transit constipation. Int. J. Colorectal Dis. 13 (1998) 208-216
111. Renzi D., Mantellini P., Calabro A., Panerai C., Amorosi A., Paladini I., Salvatori G., Garcea M.R., and Surreni C. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis. Ital. J. Gastroenterol. Hepatol. 30 (1998) 62-70
112. Renzi D., Pellegrini B., Tonelli F., Surrenti C., and Calabro A. Sunstance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine. Am. J. Pathol. 157 (2000) 1511-1522
113. Rettenbacher M., and Reubi J.C. Localization and characterisation of neuropeptide receptors in the human colon. Naunyn Schmiedeberg's Arch. Pharmacol. 364 (2001) 291-304
114. Riegler G., and Esposito I. Bristol scale stool form. A still valid help in medical practice and clinical research. Tech. Coloproctology 5 (2001) 163-164
115. Santicioli P., Giuliani S., Patacchini R., Tramontana M., Criscuoli M., and Maggi C.A. MEN11420, a potent and selective tachykinin NK2 receptor antagonist in the guinea-pig and human colon. Naunyn Schmiedeberg's Arch. Pharmacol. 356 (1997) 678-688
116. Scheurer U., Drack E., and Halter F. Substance P activates rat colonic motility via excitatory and inhibitory neuronal pathways and direct action on muscles. J. Pharmacol. Exp. Ther. 271 (1994) 7-13
117. Schmidt P.T., Lordal M., Gazelius B., and Hellstrom P.M. Tachykinins potently stimulate human small bowel blood flow: a laser Doppler flowmetry study in humans. Gut s2 (2003) 53-56
118. Schmidt B., Hammer J., Holzer P., and Hammer H.F. Chemical nociception in the jejunum induced by capsaicin. Gut 53 (2004) 1109-1116
119. Schneider J., Jehle E.C., Starlinger M.J., Neunlist M., Michel K., Hoppe S., and Schemann M. Neurotransmitter coding of enteric neurones in the submucous plexus is changed in non-inflamed rectum of patients with Crohn's disease. Neurogastroenterol. Motil. 13 (2001) 255-264
120. Simren M., Stotzer P.O., Sjovall H., Abrahamsson H., and Bjornsson E.S. Abnormal levels of neuropeptide Y and peptide YY in the colon in irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol. 15 (2003) 55-62
121. Sjolund K., Sanden G., Hakanson R., and Sundler F. Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 85 (1983) 1120-1130
122. Sjolund K., Schaffalitzky O.B., Muckadell D.E., Fahrenkrug J., Hakanson R., Peterson B.G., and Sundler F. Peptide containing nerve fibres in the gut wall in Crohn's disease. Gut 24 (1983) 724-733
123. Sjolund K., Fasth S., Ekman R., Hulten L., Jiborn H., Nordgren S., and Sundler F. Neuropeptides in idiopathic chronic constipation (slow transit constipation). Neurogastrenterol. Motil. 9 (1997) 143-150
124. Smith A.S., and Smid S.D. Impaired capsaicin and neurokinin-evoked colonic motility in inflammatory bowel disease. J. Gastroenterol. Hepatol. 20 (2005) 697-704
125. Smith V.C., Sagot M.A., Couraud J.Y., and Buchan A.M. Localisation of the neurokinin 1 (NK1-1) receptor in the human antrum and duodenum. Neurosci. Lett. 253 (1998) 49-52
126. Smith V.C., Sagot M.A., Wong H., and Buchan A.M.J. Cellular expression of the neurokinin 1 receptor in the human antrum. J. Auton. Nerv. Syst. 79 (2000) 165-172
127. Stanton M.P., Hengel P.T., Southwell B.R., Chow C.W., Keck J., Hutson J.M., and Bornstein J.C. Cholinergic transmission to colonic circular muscle of children with slow-transit constipation is unimpaired but transmission via NK2 receptors is lacking. Neurogastroenterol. Motil. 15 (2003) 669-678
128. Sternini C., Anderson K., Frantz G., Krause J.E., and Brecha N. Expression of substance P/neurokinin A-encoding preprotachykinin messenger ribonucleic acids in the rat enteric nervous system. Gastroenterology 97 (1989) 348-356
129. Tomita R., Munakata K., Aoki N., Tanjoh K., and Kurosu Y. A study on the peptidergic neves (VIP, substance P) in the colon of patients with diverticular disease. Regul. Pept. 46 (1993) 244-246
130. Tonini M., Spelta V., De Ponti F., De Giorgio R., D'Agostino G., Stanghellini V., Corinaldesi R., Sternini C., and Crema F. Tachykinin-dependent and independent components of peristalsis in the guinea pig isolated distal colon. Gastroenterology 120 (2001) 938-945
131. Tough I.R., Lewis C.A., Fozard J., and Cox H.M. Dual and selective antagonism of neurokinin NK1 and NK2 receptor-mediated responses in human colon mucosa. Naunyn-Schmiedeberg's Arch. Pharmacol. 367 (2003) 104-108
132. Toulouse M., Coelho A.M., Fioramonti J., Lecci A., and Bueno C.A. Role of tachykinin NK2 receptors in normal and altered rectal sensitivity in rats. Br. J. Pharmacol. 129 (2000) 193-199
133. Trafton J.A., Abbadie C., and Basbaum A.I. Differential contribution of substance P and neurokinin A to spinal cord neurokinin-1 receptor signalling in the rat. J. Neurosci. 21 (2001) 3656-3664
134. Tzavella K., Riepl R.L., Klauser A.G., Voderholzer W.A., Schindlbeck N.E., and Muller-Lissner S.A. Decreased substance P levels in rectal biopsies from patients with slow transit constipation. Eur. J. Gastroenterol. Hepatol. 8 (1996) 1207-1211
135. Vento P., Kiviluoto T., Keranen U., Jarvinen H.J., Kivilaakso E., and Soinila S. Quantitative comparison of growth-associated protein-43 and substance P in ulcerative colitis. J. Histochem. Cytochem. 49 (2001) 749-757
136. Wang L.H., Fang X.-C., and Pan G.-Z. Bacillary dysentery as a causative factor of irritable bowel syndrome. Gut 53 (2004) 1096-1101
137. Warner F.J., Liu L., Lubowski D.Z., and Burcher E. Circular muscle contraction, messenger signalling and localization of binding sites for neurokinin A in human sigmoid colon. Clin. Exp. Pharmacol. Physiol. 27 (2000) 928-933
138. Watanabe T., Kubota Y., and Muto T. Substance P containing nerve fibres in rectal mucosa of ulcerative colitis. Dis. Colon Rectum 40 (1997) 718-725
139. Wattchow D.A., Porter A., Brookes S.J.H., and Costa M. The polarity of neurochemically defined myenteric neurons in the human colon. Gastroenterology 113 (1997) 497-506
140. Weinstock J.V. The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses. Front. Biosci. 1 (2004) 1936-1943
141. Yunker A.M.R., Krause J.E., and Roth K.A. Neurokinin B- and substance P-like immunoreactivity are co-localized in enteric nerves of rat ileum. Regul. Pept. 80 (1999) 67-74
142. 2+ influx pathways mediate tachykinin receptor-induced contraction in circular muscle of guinea-pig colon. Eur. J. Pharmacol. 255 (1994) 9-15
143. Zagorodnyuk V., Santicioli P., Turini D., and Maggi C.A. Tachykinin NK1 and NK2 receptors mediate a non-adrenergic non-cholinergic excitatory neuromuscular transmission in the human ileum. Neuropeptides 31 (1997) 265-271